Nirupama Tamirisa is a Alpharetta, Georgia based psychiatrist who is specialized in Child & Adolescent. Active license number of Nirupama Tamirisa is R8495 for Psychiatry in Texas. Her current practice location is 2575 Northwinds Pkwy, Alpharetta. Patients can reach her at 800-930-0748. Nirupama Tamirisa is M.D. in Child & Adolescent and her NPI number (Unique professional ID assigned by NPPES) is 1700226172. Nirupama Tamirisa has done additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Complete Profile:
Nirupama Tamirisa speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1700226172
NPI Enumeration Date:
01 Jul, 2013
NPI Last Update On:
05 Jul, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Nirupama Tamirisa are as mentioned below.
License Number
Specialization
State
Status
R8495
Psychiatry
Texas
Primary
R8495
Child & Adolescent
Texas
Secondary
2013025717
Student in an Organized Health Care Education/Training Program
Missouri
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Nirupama Tamirisa 1025 E 32nd St, Austin, Texas
Zip:
78705-2714
Phone Number:
512-544-5253
Patients can reach Nirupama Tamirisa at 2575 Northwinds Pkwy, Alpharetta, Georgia or can call to book an appointment on 800-930-0748.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.